Company: G
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001398659-25-000098
Chunk: 143

Company: Genpact LTD
Filing Date: 2025-08-11
Form: 10-Q
Item: Part I, Item 8
Chunk 143
---
6,132, to the Consumer and Healthcare segment in the amount of $88,519 and to the High Tech and Manufacturing segment in the amount of $17,274. The goodwill arising from this acquisition is not deductible for income tax purposes. The goodwill represents primarily the acquired capabilities and other benefits expected to result from combining the acquired operations with those of the Company.Acquisition-related costs of $1,310 have been included in selling, general and administrative expenses as incurred. In connection with the acquisition, the Company also acquired certain assets with a value of $6,954, assumed certain liabilities amounting to $2,408 and recognized a net deferred tax liability of $14,060. The results of operations of the acquired business and the fair value of the acquired assets and assumed liabilities are included in the Company’s consolidated financial statements with effect from the date of the acquisition.

18

GENPACT LIMITED AND ITS SUBSIDIARIESNotes to the Consolidated Financial Statements(Unaudited)(In thousands, except per share data and share count)

4. Accounts receivable, net of allowance for credit losses

The following table provides details of the Company’s allowance for credit losses on accounts receivable: Year ended December 31, 2024Six months ended June 30, 2025Opening balance as of January 1$18,278 $12,094 Additions (net), charged to income statement7,582 17,822 Deductions/effect of exchange rate fluctuations(13,766)(3,086)Closing balance$12,094 $26,830 Accounts receivable were $1,210,700 and $1,293,483, and allowances for credit losses were $12,094 and $26,830, resulting in net accounts receivable balances of $1,198,606 and $1,266,653 as of December 31, 2024 and June 30, 2025, respectively.In addition, deferred billings were $130,253 and $187,392 and allowances for credit losses on deferred billings were $7,320 and $7,861, resulting in net deferred billings balances of $122,933 and $179,531 as of December 31, 2024 and June 30, 2025, respectively.During the three months ended June 30, 2024 and 2025, the Company recorded a charge of $1,338 and $1,989, respectively, and for the six months